The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury
Open accessAbstract
During the transition from acute to chronic stages of recovery after spinal cord injury (SCI), there is an evolving state of immunologic dysfunction that exacerbates the problems associated with the more clinically obvious neurologic deficits. Since injury directly affects cells embedded within the “immune privileged/specialized” milieu of the spinal cord, maladaptive or inefficient responses are likely to occur. Collectively, these responses qualify as part of the continuum of “SCI disease” and are important therapeutic targets to improve neural repair and neurological outcome. Generic immune suppressive therapies have been largely unsuccessful, mostly because nflammation and immunity exert both beneficial (plasticity enhancing) and detrimental (e.g. glia- and neurodegenerative; secondary damage) effects and these functions change over time. Moreover, “compartmentalized” investigations, limited to only intraspinal inflammation and associated cellular or molecular changes in the spinal cord, neglect the reality that the structure and function of the CNS is influenced by systemic immune challenges and that the immune system is hardwired into the nervous system. Here, we consider this interplay during the progression from acute to chronic SCI. Specifically, we survey impaired/non-resolving intraspinal inflammation and the paradox of systemic inflammatory responses in the face of ongoing chronic immune suppression and autoimmunity. The concepts of systemic inflammatory response syndrome (SIRS), compensatory anti-inflammatory response syndrome (CARS) and ‘neurogenic’ spinal cord injury-induced immune depression syndrome (SCI-IDS) are discussed as determinants of impaired ‘host-defense’ and trauma-induced autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which is impaired in individuals with UMNDs such as MS, BI, stroke, and SCI.46–50”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Immediately after injury the spinal cord undergoes massive cellular and molecular changes, including increased cell death [64, 65], infiltration of inflammation cells in the lesion [2–6], axon degeneration [7–10], and OL and myelin loss [13–16, 66, 67].”
From Delayed short-term tamoxifen treatment does not promote remyelination or neuron sparing after spinal cord injury (2020) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 12,401
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772 · cited 2×
“In response to injury or infection, SIRS develops but in parallel CARS is triggered to terminate inflammation (Hotchkiss et al., 2013a, b).”
BackgroundResolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 5×
“Failure to resolve inflammation results in aberrant tissue remodeling and organ dysfunction (Nathan and Ding, 2010; Serhan and Savill, 2005; Serhan et al., 2007).”
BackgroundInfluentialElenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01470-4 · Cited by 2,252 · cited 3×
“Functional cross-talk between the nervous and immune systems is achieved by the autonomic nervous system (ANS) and the hypothalamic–pituitary–adrenal (HPA) axis (Elenkov et al., 2000).”
BackgroundInfluentialNathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Stroke-Associated Pneumonia: Major Advances and Obstacles
Hannawi, Y., Hannawi, B., Rao, C. P. V., Suárez, J. I., & Bershad, E. M. (2013) · Cerebrovascular Diseases · doi:10.1159/000350199 · Cited by 1,664
A blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C. D., & Haslett, C. (2002) · Nature reviews. Immunology · doi:10.1038/nri957 · Cited by 1,574 · cited 1×
“The immunologically silent, non-phlogistic clearance of apoptotic cells is crucial for maintaining tolerance to self-antigens (Savill et al., 2002; Uderhardt et al., 2012).”
BackgroundControl of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 1×
“As a consequence of SCI and subsequent neurodegeneration, such control is lost and microglia become activated (Cardona et al., 2006; Meuth et al., 2008).”
BackgroundMagliozzi, R., Howell, O. W., Vora, A., Serafini, B., Nicholas, R. S., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,486 · cited 2×
“In classical CNS inflammatory diseases (e.g., MS), ectopic lymphoidlike follicles form adjacent to large intraparenchymal inflammatory lesions (Magliozzi et al., 2007; Franciotta et al., 2008).”
Background
Cited by
Sorted by citations
Ahuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A., & Fehlings, M. G. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.18 · Cited by 2,441
Cell biology of spinal cord injury and repair
O’Shea, T. M., Burda, J. E., & Sofroniew, M. V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90608 · Cited by 598
Immune cell regulation of glia during CNS injury and disease
Greenhalgh, A. D., David, S., & Bennett, F. C. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0263-9 · Cited by 411
Recent update on basic mechanisms of spinal cord injury
Quadri, S. A., Farooqui, M., Ikram, A., Zafar, A., Khan, M. A., Suriya, S. S., Claus, C. F., Fiani, B., Rahman, M. S., Ramachandran, A., et al. (2018) · Neurosurgical Review · doi:10.1007/s10143-018-1008-3 · Cited by 360
Transplanting neural progenitor cells to restore connectivity after spinal cord injury
Fischer, I., Dulin, J. N., & Lane, M. A. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0314-2 · Cited by 303
Metadata
- Authors
- Schwab, J. M., Zhang, Y., Kopp, M. A., Brommer, B., & Popovich, P. G.
- Affiliations
- Stiftung Charité (DE)
- The Ohio State University Wexner Medical Center (US)
- Corresponding author
- Schwab, Jan M.
- Popovich, Phillip G.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 258
- Pages
- 121-129
- ISSN
- 0014-4886 (ISSN-L)
- PMC
- PMC4099970
- OpenAlex
- W1991275594
- Semantic Scholar
- 4a08f8b28fb79888e283c1be793ea654af48618a
- Cited by
- 260
- References
- 117
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 17 · 2023: 24 · 2022: 35 · 2021: 32 · 2020: 30 · 2019: 22 · 2018: 17 · 2017: 22 · 2016: 17 · 2015: 9 · 2014: 4
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-11-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS047175, R21NS067260)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- chronic spinal cord injury, neuroinflammation, systemic immune suppression, autoimmunity, traumatic spinal cord injury, systemic inflammatory response syndrome, compensatory anti-inflammatory response syndrome, immune privilege, secondary injury, glial activation, neurodegeneration, host defense
- MeSH terms
- Animals, Chronic Disease, Humans, Immune Tolerance, Inflammation, Spinal Cord Injuries, Autoimmunity, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
